Senate Finance Committee Chair Ron Wyden has released a document outlining ālegislative principlesā for controlling drug prices.
The major provisions include: Medicare price negotiation and inflation rebates, giving commercial insurers the same drug prices that Medicare negotiates, blocking a Trump-era ban on rebates, and tailoring policies to protect small biotechnology companies.
The bill also will include cost-saving measures for Medicare beneficiaries, which both parties want. Legislation from 2019 in both the House and Senate called for restructuring the Part D benefit to cap beneficiariesā annual out-of-pocket spending and reduce the governmentās responsibility for catastrophic costs.
Senate Finance Committee: Principles for Drug Pricing Reform
Wyden Releases Principles For Lowering Drug Prices for Americans
Senate Finance Chairman Releases Legislative Principles to Lower Drug Prices
WSC
June 23, 2021 10:26 am
Senate Finance Committee Chair Ron Wyden has released a document outlining ālegislative principlesā for controlling drug prices.
The major provisions include: Medicare price negotiation and inflation rebates, giving commercial insurers the same drug prices that Medicare negotiates, blocking a Trump-era ban on rebates, and tailoring policies to protect small biotechnology companies.
The bill also will include cost-saving measures for Medicare beneficiaries, which both parties want. Legislation from 2019 in both the House and Senate called for restructuring the Part D benefit to cap beneficiariesā annual out-of-pocket spending and reduce the governmentās responsibility for catastrophic costs.
Senate Finance Committee: Principles for Drug Pricing Reform
Wyden Releases Principles For Lowering Drug Prices for Americans